drugset / Trial / NCT01742091
A Multiple Dose Study of LY2541546 in Healthy Postmenopausal Women
RandomizedParallel-groupDouble-blindBasic science
Summary
The purpose of this study is to assess the safety and side effects of multiple doses of LY2541546 in postmenopausal women when given subcutaneously (injection just under the skin) and intravenously (directly into a vein). The study will also test how long it takes the study drug to get into the body, how long it takes the body to get rid of it, the overall effect of the study drug on the body, and whether antibodies to the study drug are formed.
Timeline
- Start
- 2009-09
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Blosozumab | Monoclonal antibody | 180 mg | Subcutaneous |
| Subject | Blosozumab | Monoclonal antibody | 270 mg | Subcutaneous |
| Subject | Blosozumab | Monoclonal antibody | 540 mg | Subcutaneous |
| Subject | Blosozumab | Monoclonal antibody | 750 mg | Subcutaneous |
Indications
No indication recorded.